{"id":462780,"date":"2026-06-23T14:10:09","date_gmt":"2026-06-23T17:10:09","guid":{"rendered":"https:\/\/mrnews.com.br\/index.php\/2026\/06\/23\/anvisa-aprova-medicamento-nao-hormonal-contra-sintomas-da-menopausa\/"},"modified":"2026-06-23T14:10:09","modified_gmt":"2026-06-23T17:10:09","slug":"anvisa-aprova-medicamento-nao-hormonal-contra-sintomas-da-menopausa","status":"publish","type":"post","link":"https:\/\/mrnews.com.br\/index.php\/2026\/06\/23\/anvisa-aprova-medicamento-nao-hormonal-contra-sintomas-da-menopausa\/","title":{"rendered":"Anvisa aprova medicamento n\u00e3o hormonal contra sintomas da menopausa"},"content":{"rendered":"<p>Por EBC, <\/p>\n<div>\n<p><strong>A Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (Anvisa) aprovou o fezolinetanto, terapia n\u00e3o hormonal no formato oral indicada para o tratamento das ondas de calor e suores noturnos, associados \u00e0 menopausa.<\/strong><\/p>\n<p><strong>O medicamento ser\u00e1 vendido no Brasil com o nome comercial Veoza<\/strong>, produzido pela Astellas Farma. Em nota, o fabricante informou que o processo de aprova\u00e7\u00e3o incluiu tr\u00eas ensaios cl\u00ednicos de fase 3 com mais de 3 mil indiv\u00edduos inscritos na Europa, nos Estados Unidos e no Canad\u00e1.<\/p>\n<p>\u201cAntes da menopausa, h\u00e1 um equil\u00edbrio entre os estrog\u00eanios (horm\u00f4nios produzidos pelos ov\u00e1rios da mulher) e a neurocinina B (NKB), uma subst\u00e2ncia qu\u00edmica do c\u00e9rebro. Essa estabilidade regula o centro de controle de temperatura do corpo localizado em uma \u00e1rea espec\u00edfica do c\u00e9rebro\u201d, destacou o laborat\u00f3rio.<\/p>\n<p>\u201c\u00c0 medida em que o corpo passa pela menopausa, os estrog\u00eanios diminuem e esse equil\u00edbrio \u00e9 interrompido. Essa desarmonia pode levar \u00e0s ondas de calor e aos suores noturnos\u201d, completou.<\/p>\n<p><strong>Ainda de acordo com o fabricante, sintomas vasomotores moderados e intensos, os chamados fogachos, afetam at\u00e9 80% das mulheres com idade entre 40 e 65 anos.<\/strong><\/p>\n<blockquote>\n<p>\u201cNo Brasil, 36,2% das mulheres na menopausa (40-65 anos) sofrem com SVM moderados a intensos, uma taxa que supera significativamente a m\u00e9dia de 15,6% observada globalmente\u201d.<\/p>\n<\/blockquote>\n<p>De acordo com o laborat\u00f3rio, entre as mulheres que apresentam esses sintomas, quase 70% das brasileiras (69,9%) classificam as ondas de calor e os suores noturnos como intensos,&#8221;indicando um impacto severo na qualidade de vida, produtividade e sono\u201d.\u00a0<\/p>\n<p>\u00a0<\/p>\n<p>      <!-- Relacionada --><\/p>\n<p>            <!-- Relacionada -->\n    <\/div>\n","protected":false},"excerpt":{"rendered":"<p>Por EBC, A Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (Anvisa) aprovou o fezolinetanto, terapia n\u00e3o hormonal no formato oral indicada para o tratamento das ondas de calor e suores noturnos, associados \u00e0 menopausa. O medicamento ser\u00e1 vendido no Brasil com o nome comercial Veoza, produzido pela Astellas Farma. Em nota, o fabricante informou que o processo &hellip;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_post_was_ever_published":false},"categories":[2,12225,4],"tags":[],"class_list":["post-462780","post","type-post","status-publish","format-standard","hentry","category-entretenimento","category-noticias","category-servicos"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Anvisa aprova medicamento n\u00e3o hormonal contra sintomas da menopausa<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/agenciabrasil.ebc.com.br\/saude\/noticia\/2026-06\/anvisa-aprova-medicamento-nao-hormonal-contra-sintomas-da-menopausa\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Anvisa aprova medicamento n\u00e3o hormonal contra sintomas da menopausa\" \/>\n<meta property=\"og:description\" content=\"Por EBC, A Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (Anvisa) aprovou o fezolinetanto, terapia n\u00e3o hormonal no formato oral indicada para o tratamento das ondas de calor e suores noturnos, associados \u00e0 menopausa. O medicamento ser\u00e1 vendido no Brasil com o nome comercial Veoza, produzido pela Astellas Farma. Em nota, o fabricante informou que o processo &hellip;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/agenciabrasil.ebc.com.br\/saude\/noticia\/2026-06\/anvisa-aprova-medicamento-nao-hormonal-contra-sintomas-da-menopausa\" \/>\n<meta property=\"og:site_name\" content=\"MRNews\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/eaipahpah\/?locale2=pt_BR\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-23T17:10:09+00:00\" \/>\n<meta name=\"author\" content=\"MR News\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@conspirou\" \/>\n<meta name=\"twitter:site\" content=\"@conspirou\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"MR News\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/agenciabrasil.ebc.com.br\\\/saude\\\/noticia\\\/2026-06\\\/anvisa-aprova-medicamento-nao-hormonal-contra-sintomas-da-menopausa#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/mrnews.com.br\\\/index.php\\\/2026\\\/06\\\/23\\\/anvisa-aprova-medicamento-nao-hormonal-contra-sintomas-da-menopausa\\\/\"},\"author\":{\"name\":\"MR News\",\"@id\":\"https:\\\/\\\/mrnews.com.br\\\/#\\\/schema\\\/person\\\/be3203154562a9f207407861cef7827b\"},\"headline\":\"Anvisa aprova medicamento n\u00e3o hormonal contra sintomas da menopausa\",\"datePublished\":\"2026-06-23T17:10:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/mrnews.com.br\\\/index.php\\\/2026\\\/06\\\/23\\\/anvisa-aprova-medicamento-nao-hormonal-contra-sintomas-da-menopausa\\\/\"},\"wordCount\":266,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/mrnews.com.br\\\/#organization\"},\"articleSection\":[\"ENTRETENIMENTO\",\"NOTICIAS\",\"SERVI\u00c7OS\"],\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/agenciabrasil.ebc.com.br\\\/saude\\\/noticia\\\/2026-06\\\/anvisa-aprova-medicamento-nao-hormonal-contra-sintomas-da-menopausa#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/mrnews.com.br\\\/index.php\\\/2026\\\/06\\\/23\\\/anvisa-aprova-medicamento-nao-hormonal-contra-sintomas-da-menopausa\\\/\",\"url\":\"https:\\\/\\\/agenciabrasil.ebc.com.br\\\/saude\\\/noticia\\\/2026-06\\\/anvisa-aprova-medicamento-nao-hormonal-contra-sintomas-da-menopausa\",\"name\":\"Anvisa aprova medicamento n\u00e3o hormonal contra sintomas da menopausa\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/mrnews.com.br\\\/#website\"},\"datePublished\":\"2026-06-23T17:10:09+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/agenciabrasil.ebc.com.br\\\/saude\\\/noticia\\\/2026-06\\\/anvisa-aprova-medicamento-nao-hormonal-contra-sintomas-da-menopausa#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/agenciabrasil.ebc.com.br\\\/saude\\\/noticia\\\/2026-06\\\/anvisa-aprova-medicamento-nao-hormonal-contra-sintomas-da-menopausa\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/agenciabrasil.ebc.com.br\\\/saude\\\/noticia\\\/2026-06\\\/anvisa-aprova-medicamento-nao-hormonal-contra-sintomas-da-menopausa#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/mrnews.com.br\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Anvisa aprova medicamento n\u00e3o hormonal contra sintomas da menopausa\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/mrnews.com.br\\\/#website\",\"url\":\"https:\\\/\\\/mrnews.com.br\\\/\",\"name\":\"MRNews\",\"description\":\"MRNews Jogos de hoje da TV, transmiss\u00f5es ao vivo, Not\u00edcias de futebol, Jogos ao vivo, Lives, resumo de novelas, Programa\u00e7\u00e3o da Globo, A Fazenda e BBB\",\"publisher\":{\"@id\":\"https:\\\/\\\/mrnews.com.br\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/mrnews.com.br\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/mrnews.com.br\\\/#organization\",\"name\":\"MRNews\",\"url\":\"https:\\\/\\\/mrnews.com.br\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/mrnews.com.br\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/mrnews.com.br\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/MRNEws.png\",\"contentUrl\":\"https:\\\/\\\/mrnews.com.br\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/MRNEws.png\",\"width\":1254,\"height\":1254,\"caption\":\"MRNews\"},\"image\":{\"@id\":\"https:\\\/\\\/mrnews.com.br\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/eaipahpah\\\/?locale2=pt_BR\",\"https:\\\/\\\/x.com\\\/conspirou\",\"https:\\\/\\\/www.instagram.com\\\/eai_pahpah\",\"https:\\\/\\\/br.pinterest.com\\\/mrnewsn\\\/boards\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCacgnpznQ61fifLWr1tQ-vA?view_as=subscriber\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/mrnews.com.br\\\/#\\\/schema\\\/person\\\/be3203154562a9f207407861cef7827b\",\"name\":\"MR News\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/04084e6d73c042b8646e7c17b494073bf0ede3ea13c7105cfc45cbbbc28385a4?s=96&d=monsterid&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/04084e6d73c042b8646e7c17b494073bf0ede3ea13c7105cfc45cbbbc28385a4?s=96&d=monsterid&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/04084e6d73c042b8646e7c17b494073bf0ede3ea13c7105cfc45cbbbc28385a4?s=96&d=monsterid&r=g\",\"caption\":\"MR News\"},\"description\":\"Especializado em jornalismo colaborativo pela FTP em n\u00edvel de p\u00f3s-gradua\u00e7\u00e3o. suporte@oimeliga.combr\",\"sameAs\":[\"HUGO R.\",\"Admin\"],\"url\":\"https:\\\/\\\/mrnews.com.br\\\/index.php\\\/author\\\/admin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Anvisa aprova medicamento n\u00e3o hormonal contra sintomas da menopausa","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/agenciabrasil.ebc.com.br\/saude\/noticia\/2026-06\/anvisa-aprova-medicamento-nao-hormonal-contra-sintomas-da-menopausa","og_locale":"pt_BR","og_type":"article","og_title":"Anvisa aprova medicamento n\u00e3o hormonal contra sintomas da menopausa","og_description":"Por EBC, A Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (Anvisa) aprovou o fezolinetanto, terapia n\u00e3o hormonal no formato oral indicada para o tratamento das ondas de calor e suores noturnos, associados \u00e0 menopausa. O medicamento ser\u00e1 vendido no Brasil com o nome comercial Veoza, produzido pela Astellas Farma. Em nota, o fabricante informou que o processo &hellip;","og_url":"https:\/\/agenciabrasil.ebc.com.br\/saude\/noticia\/2026-06\/anvisa-aprova-medicamento-nao-hormonal-contra-sintomas-da-menopausa","og_site_name":"MRNews","article_publisher":"https:\/\/www.facebook.com\/eaipahpah\/?locale2=pt_BR","article_published_time":"2026-06-23T17:10:09+00:00","author":"MR News","twitter_card":"summary_large_image","twitter_creator":"@conspirou","twitter_site":"@conspirou","twitter_misc":{"Escrito por":"MR News","Est. tempo de leitura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/agenciabrasil.ebc.com.br\/saude\/noticia\/2026-06\/anvisa-aprova-medicamento-nao-hormonal-contra-sintomas-da-menopausa#article","isPartOf":{"@id":"https:\/\/mrnews.com.br\/index.php\/2026\/06\/23\/anvisa-aprova-medicamento-nao-hormonal-contra-sintomas-da-menopausa\/"},"author":{"name":"MR News","@id":"https:\/\/mrnews.com.br\/#\/schema\/person\/be3203154562a9f207407861cef7827b"},"headline":"Anvisa aprova medicamento n\u00e3o hormonal contra sintomas da menopausa","datePublished":"2026-06-23T17:10:09+00:00","mainEntityOfPage":{"@id":"https:\/\/mrnews.com.br\/index.php\/2026\/06\/23\/anvisa-aprova-medicamento-nao-hormonal-contra-sintomas-da-menopausa\/"},"wordCount":266,"commentCount":0,"publisher":{"@id":"https:\/\/mrnews.com.br\/#organization"},"articleSection":["ENTRETENIMENTO","NOTICIAS","SERVI\u00c7OS"],"inLanguage":"pt-BR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/agenciabrasil.ebc.com.br\/saude\/noticia\/2026-06\/anvisa-aprova-medicamento-nao-hormonal-contra-sintomas-da-menopausa#respond"]}]},{"@type":"WebPage","@id":"https:\/\/mrnews.com.br\/index.php\/2026\/06\/23\/anvisa-aprova-medicamento-nao-hormonal-contra-sintomas-da-menopausa\/","url":"https:\/\/agenciabrasil.ebc.com.br\/saude\/noticia\/2026-06\/anvisa-aprova-medicamento-nao-hormonal-contra-sintomas-da-menopausa","name":"Anvisa aprova medicamento n\u00e3o hormonal contra sintomas da menopausa","isPartOf":{"@id":"https:\/\/mrnews.com.br\/#website"},"datePublished":"2026-06-23T17:10:09+00:00","breadcrumb":{"@id":"https:\/\/agenciabrasil.ebc.com.br\/saude\/noticia\/2026-06\/anvisa-aprova-medicamento-nao-hormonal-contra-sintomas-da-menopausa#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/agenciabrasil.ebc.com.br\/saude\/noticia\/2026-06\/anvisa-aprova-medicamento-nao-hormonal-contra-sintomas-da-menopausa"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/agenciabrasil.ebc.com.br\/saude\/noticia\/2026-06\/anvisa-aprova-medicamento-nao-hormonal-contra-sintomas-da-menopausa#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/mrnews.com.br\/"},{"@type":"ListItem","position":2,"name":"Anvisa aprova medicamento n\u00e3o hormonal contra sintomas da menopausa"}]},{"@type":"WebSite","@id":"https:\/\/mrnews.com.br\/#website","url":"https:\/\/mrnews.com.br\/","name":"MRNews","description":"MRNews Jogos de hoje da TV, transmiss\u00f5es ao vivo, Not\u00edcias de futebol, Jogos ao vivo, Lives, resumo de novelas, Programa\u00e7\u00e3o da Globo, A Fazenda e BBB","publisher":{"@id":"https:\/\/mrnews.com.br\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mrnews.com.br\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/mrnews.com.br\/#organization","name":"MRNews","url":"https:\/\/mrnews.com.br\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/mrnews.com.br\/#\/schema\/logo\/image\/","url":"https:\/\/mrnews.com.br\/wp-content\/uploads\/2026\/08\/MRNEws.png","contentUrl":"https:\/\/mrnews.com.br\/wp-content\/uploads\/2026\/08\/MRNEws.png","width":1254,"height":1254,"caption":"MRNews"},"image":{"@id":"https:\/\/mrnews.com.br\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/eaipahpah\/?locale2=pt_BR","https:\/\/x.com\/conspirou","https:\/\/www.instagram.com\/eai_pahpah","https:\/\/br.pinterest.com\/mrnewsn\/boards\/","https:\/\/www.youtube.com\/channel\/UCacgnpznQ61fifLWr1tQ-vA?view_as=subscriber"]},{"@type":"Person","@id":"https:\/\/mrnews.com.br\/#\/schema\/person\/be3203154562a9f207407861cef7827b","name":"MR News","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/secure.gravatar.com\/avatar\/04084e6d73c042b8646e7c17b494073bf0ede3ea13c7105cfc45cbbbc28385a4?s=96&d=monsterid&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/04084e6d73c042b8646e7c17b494073bf0ede3ea13c7105cfc45cbbbc28385a4?s=96&d=monsterid&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/04084e6d73c042b8646e7c17b494073bf0ede3ea13c7105cfc45cbbbc28385a4?s=96&d=monsterid&r=g","caption":"MR News"},"description":"Especializado em jornalismo colaborativo pela FTP em n\u00edvel de p\u00f3s-gradua\u00e7\u00e3o. suporte@oimeliga.combr","sameAs":["HUGO R.","Admin"],"url":"https:\/\/mrnews.com.br\/index.php\/author\/admin\/"}]}},"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/pa2Qf7-1Woc","amp_enabled":true,"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/mrnews.com.br\/index.php\/wp-json\/wp\/v2\/posts\/462780","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mrnews.com.br\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mrnews.com.br\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mrnews.com.br\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/mrnews.com.br\/index.php\/wp-json\/wp\/v2\/comments?post=462780"}],"version-history":[{"count":0,"href":"https:\/\/mrnews.com.br\/index.php\/wp-json\/wp\/v2\/posts\/462780\/revisions"}],"wp:attachment":[{"href":"https:\/\/mrnews.com.br\/index.php\/wp-json\/wp\/v2\/media?parent=462780"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mrnews.com.br\/index.php\/wp-json\/wp\/v2\/categories?post=462780"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mrnews.com.br\/index.php\/wp-json\/wp\/v2\/tags?post=462780"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}